Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to triazolopyrimidine derivatives and physiologically acceptable salts thereof which are useful as anti-allergic agent.
BACKGROUND OF THE INVENTION
It is well known that a chemical mediator released by antigen-antibody reaction, e.g., histamine, plays an
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention substantially relates to the technical field of drugs, cosmetics, medical products, disinfecting products, healthcare products, food, and household chemicals, and more specifically, relates to a mussel adhesive protein product and a use thereof for
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to certain novel 3-nitrocoumarin derivatives, to a method for their preparation, to pharmaceutical compositions comprising such compounds and to their use in the treatment of certain allergic conditions.
It is known that some types of cells are activated by certain
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to pharmaceutical compositions which are useful in the inhibition of the effects of certain types of antigen-antibody reactions, and are therefore useful in the prophylaxis and treatment of diseases associated with allergic or immunological reactions, e.g. certain types of
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Technical Field
The present invention relates to a nitrogen-containing tricyclic compound useful as a medicine, a medicine containing the same and processes for producing the same. More particularly, it relates to a novel nitrogen-containing tricyclic compound useful
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Technical Field
The present invention relates to a nitrogen-containing tricyclic compound useful as a medicine, a medicine containing the same and processes for producing the same. More particularly, it relates to a novel nitrogen-containing tricyclic compound useful
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Technical Field
The present invention relates to a nitrogen-containing tricyclic compound useful as a medicine, a medicine containing the same and processes for producing the same. More particularly, it relates to a novel nitrogen-containing tricyclic compound useful
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This is a continuation in-part of PCT/JP90/00905, filed Jul. 12, 1990.
FIELD OF THE INVENTION
The present invention relates to a novel styryl compound, a pharmaceutically acceptable salt thereof or an ester thereof which possesses leukotriene-antagonistic actions and inhibitory actions against
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to 5:6-benzo-.gamma.-pyrone derivatives, to a process for their preparation and to pharmaceutical compositions containing them.
In particular, an object of the present invention is represented by new 5:6-benzo-.gamma.-pyrone derivatives having the following general formula (I)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is related to commonly assigned U.S. application Ser. Nos. 578,413, abandoned, for "Tumor Reducing Compositions," Allen, and 578,412, abandoned, "Antioxidant Compounds and Methods of Synthesis," Allen, et al., being filed in the U.S. Patent
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
This invention relates to benzothiophenes, particularly 3-hydroxybenzothiophenes having the 2-sulfide side chains, for example, ##STR1##
These novel benzothiophenes are found to be effective and specific 5-lipoxygenase inhibitors and are therefore useful in the treatment
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to novel diazine-ethenylphenyl oxamic acids and esters and salts thereof, to methods of preparing these compounds, to pharmaceutical compositions containing them as active ingredients, and to methods of using them for the treatment of immunological, inflammatory and allergic
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention concerns a process for in vitro analysis of toxic and allergenic substances. Substances intended for use as pharmaceuticals, food additives, cosmetic or hygienic products, industrial chemicals and other sub- stances are analysed for adverse reactions. Such reactions may be
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD
Described are novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof.
##STR00002##
The present invention also
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD
Described are novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof.
##STR00002##
The present invention also
Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse. * Kogu teave põhineb avaldatud teaduslikel uuringutel